| Literature DB >> 30007787 |
Antonio López-Sanromán1, Joan Clofent2, Esther Garcia-Planella3, Luis Menchén4, Pilar Nos5, Iago Rodríguez-Lago6, Eugeni Domènech7.
Abstract
Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide. Its approved indications are reviewed, as well as other clinical scenarios in which it could play a role, in order to facilitate its use and improve the accuracy of its prescription.Entities:
Keywords: Budesonida; Budesonide; Colitis ulcerosa; Crohn's disease; Enfermedad de Crohn; Enfermedad inflamatoria intestinal; Inflammatory bowel disease; Ulcerative colitis
Mesh：
Substances：
Year: 2018 PMID： 30007787 DOI： 10.1016/j.gastrohep.2018.05.013
Source DB: PubMed Journal: Gastroenterol Hepatol ISSN： 0210-5705 Impact factor: 2.102